Tru Independence LLC Novo Cure LTD Transaction History

Tru Independence LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$116.17 - $194.55 $29,042 - $48,637	-250 Closed	0 $0
Q2 2021 Aug 03, 2021	BUY	$130.4 - $225.58 $32,600 - $56,395	250 New	250 $55,000
Q1 2021 May 20, 2021	SELL	$124.11 - $190.17 $31,399 - $48,113	-253 Closed	0 $0
Q4 2020 Mar 09, 2021	BUY	$112.16 - $174.14 $28,376 - $44,057	253 New	253 $43,000
Q3 2020 Nov 19, 2020	SELL	$58.05 - $111.31 $14,512 - $27,827	-250 Closed	0 $0
Q2 2020 Aug 19, 2020	BUY	$57.2 - $74.41 $14,300 - $18,602	250 New	250 $14,000

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.07B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Tru Independence LLC, based on Form 13F filings with the SEC.

Stay updated on Tru Independence LLC with notifications on news.